Indeed, ALT is a glucogenic enzyme and is regarded as a surrogate marker of hepatic IR, nonalcoholic fatty liver disease (NAFLD) [11, 12]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.